
Welcome to the home page of Doris Pharmaceuticals. We are committed to develop drugs for hard-to-treat central nervous system (CNS) diseases and oncology products in the Asia-Pacific region.
Many neurological and psychiatric illnesses are still not optimally treatable, or have no therapeutic agents available to the clinician. A number of innovative anti-cancer drugs are in development in the West but not yet in Japan and Asia. Doris Pharmaceuticals aims to fill this gap with innovative drugs for these illnesses.